Mexico health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
November 2025 — Vol. 2, No. 11
Page 3 of 4 of this archive, newest first.
Also filed — page 3
the rolling newsroom, November 2025Tianjin export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
What the new Sweden guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The online reseller trading as Adamant Research Supply closes after 3 years
A proper account of an operation that existed, and of what closing it cost.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Portugal pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
From the floor in Tianjin: 20 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
The 8-day notice: how a compounding wind-down works in Spain
The document is four pages. Three of them are about dates.
From the floor in Zhuhai: 21 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Australia pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
Changsha export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a FGP survodutide lot at 95.6%, against 92.9% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
The 26-day notice: how a compounding wind-down works in Poland
The document is four pages. Three of them are about dates.
What changed at HJ in November, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Tianjin retatrutide lot lands 3.7 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
From the floor in Wuxi: 11 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The United Arab Emirates health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
Hong Kong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
From the floor in Suzhou: 14 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Nigeria caps liraglutide prescribing to 15 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What a 35% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
What the new Norway guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Independent analysis puts a CPC dulaglutide lot at 96.5%, against 94.8% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
Denmark declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Xi'an export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.